Article Versions Notes

Szász JA, Constantin VA, Orbán-Kis K, Bancu LA, Bataga SM, Ciorba M, Nagy E, Neagoe MR, Mihály I, Szász RM, et al. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics. 2022; 14(6):1115. https://doi.org/10.3390/pharmaceutics14061115

Szász, József Attila, Viorelia Adelina Constantin, Károly Orbán-Kis, Ligia Ariana Bancu, Simona Maria Bataga, Marius Ciorba, Előd Nagy, Mircea Radu Neagoe, István Mihály, Róbert Máté Szász, and et al. 2022. "Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience" Pharmaceutics 14, no. 6: 1115. https://doi.org/10.3390/pharmaceutics14061115

Szász, J. A., Constantin, V. A., Orbán-Kis, K., Bancu, L. A., Bataga, S. M., Ciorba, M., Nagy, E., Neagoe, M. R., Mihály, I., Szász, R. M., Kelemen, K., Simu, M., & Szatmári, S. (2022). Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: Observations and Dilemmas after 10 Years of Real-Life Experience. Pharmaceutics, 14(6), 1115. https://doi.org/10.3390/pharmaceutics14061115